Several indirect mechanisms may explain why some patients report muscle pain or weakness while taking GLP-1 medications, even in the absence of direct myotoxicity
The calculator shows both so you can read either marking
Mechanism of Action: These drugs mimic the effects of glucagon-like peptide-1 (GLP-1), a hormone responsible for regulating the production of insulin and glucagon.6 Together, these hormones control blood sugar levels
(1) PT-141 synthetic peptide appears to be agonistic to melanocortin receptors, which is similar to the natural hormone alpha-MSH
The remaining 35 states (Alabama, Alaska, Arkansas, Colorado, Connecticut, Delaware, Hawaii, Idaho, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Oklahoma, Oregon, Rhode Island, South Carolina, South Dakota, Utah, Vermont, West Virginia, Wisconsin, Wyoming) follow their state PDL more closely with fewer MCO carve-outs
Moyle 2025)